These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 17003493)

  • 21. Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography.
    Frenkel S; Barzel I; Levy J; Lin AY; Bartsch DU; Majumdar D; Folberg R; Pe'er J
    Eye (Lond); 2008 Jul; 22(7):948-52. PubMed ID: 17363922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remodeling of the microenvironment by aggressive melanoma tumor cells.
    Hendrix MJ; Seftor EA; Kirschmann DA; Quaranta V; Seftor RE
    Ann N Y Acad Sci; 2003 May; 995():151-61. PubMed ID: 12814947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis.
    Chang SH; Worley LA; Onken MD; Harbour JW
    Melanoma Res; 2008 Jun; 18(3):191-200. PubMed ID: 18477893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.
    Ruf W; Seftor EA; Petrovan RJ; Weiss RM; Gruman LM; Margaryan NV; Seftor RE; Miyagi Y; Hendrix MJ
    Cancer Res; 2003 Sep; 63(17):5381-9. PubMed ID: 14500372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mouse model for primary uveal melanoma: a pilot study.
    Süsskind D; Hurst J; Rohrbach JM; Schnichels S
    Clin Exp Ophthalmol; 2017 Mar; 45(2):192-200. PubMed ID: 27505446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures.
    Valyi-Nagy K; Kormos B; Ali M; Shukla D; Valyi-Nagy T
    Mol Vis; 2012; 18():588-92. PubMed ID: 22419851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasculogenic mimicry: how convincing, how novel, and how significant?
    McDonald DM; Munn L; Jain RK
    Am J Pathol; 2000 Feb; 156(2):383-8. PubMed ID: 10666365
    [No Abstract]   [Full Text] [Related]  

  • 28. Focal adhesion kinase promotes the aggressive melanoma phenotype.
    Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
    Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The involvement of apoptosis in melanoma vasculogenic mimicry.
    Vartanian AA; Burova OS; Stepanova EV; Baryshnikov AY
    Melanoma Res; 2007 Feb; 17(1):1-8. PubMed ID: 17235236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of tumor-associated vasculatures in uveal and cutaneous melanomas.
    Bhat P; Jakobiec FA; Folberg R
    Semin Ophthalmol; 2009; 24(3):166-71. PubMed ID: 19437353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
    Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
    J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis.
    Onken MD; Worley LA; Harbour JW
    Clin Cancer Res; 2008 Jun; 14(12):3737-45. PubMed ID: 18559591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
    Hendrix MJ; Seftor EA; Seftor RE; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
    Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.
    Mourad-Zeidan AA; Melnikova VO; Wang H; Raz A; Bar-Eli M
    Am J Pathol; 2008 Dec; 173(6):1839-52. PubMed ID: 18988806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An orthotopic model for human uveal melanoma in SCID mice.
    Mueller AJ; Maniotis AJ; Freeman WR; Bartsch DU; Schaller UC; Bergeron-Lynn G; Cheng L; Taskintuna I; Chen X; Kan-Mitchell J; Folberg R
    Microvasc Res; 2002 Sep; 64(2):207-13. PubMed ID: 12204644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of EphA2 in Metastatic and Non-Metastatic Primary Uveal Melanoma].
    Vukoja V; Brandenbusch T; Tura A; Nassar K; Rohrbach DJ; Lüke M; Grisanti S; Lüke J
    Klin Monbl Augenheilkd; 2016 Mar; 232(3):290-7. PubMed ID: 26854480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of caveolin-1 and phosphoinositol-3 kinase expression in primary uveal melanomas.
    Stenzel M; Tura A; Nassar K; Rohrbach JM; Grisanti S; Lüke M; Lüke J
    Clin Exp Ophthalmol; 2016 Jul; 44(5):400-9. PubMed ID: 26590370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The identification of chromosome abnormalities associated with the invasive phenotype of uveal melanoma in vitro.
    Cross NA; Rennie IG; Murray AK; Sisley K
    Clin Exp Metastasis; 2005; 22(2):107-13. PubMed ID: 16086231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular plasticity of human melanoma cells.
    Hendrix MJ; Seftor EA; Hess AR; Seftor RE
    Oncogene; 2003 May; 22(20):3070-5. PubMed ID: 12789282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors.
    Némati F; Sastre-Garau X; Laurent C; Couturier J; Mariani P; Desjardins L; Piperno-Neumann S; Lantz O; Asselain B; Plancher C; Robert D; Péguillet I; Donnadieu MH; Dahmani A; Bessard MA; Gentien D; Reyes C; Saule S; Barillot E; Roman-Roman S; Decaudin D
    Clin Cancer Res; 2010 Apr; 16(8):2352-62. PubMed ID: 20371695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.